• Catalpol’s Protective Mechanisms in Cardio-Cerebrovascular D

  2026-07-06

  This review synthesizes current evidence on catalpol, a bioactive iridoid glucoside, and its multifaceted protective effects in cardio-cerebrovascular diseases (CVDs). The article highlights catalpol’s mechanistic pathways and translational potential, offering researchers a comprehensive understanding of its therapeutic promise and practical considerations for future studies.

• EdU Imaging Kits (488): Click Chemistry for S-Phase Detectio

  2026-07-06

  EdU Imaging Kits (488) utilize 5-ethynyl-2'-deoxyuridine and click chemistry for highly sensitive, morphology-preserving detection of S-phase DNA synthesis. This method enables robust cell proliferation assays, outperforming traditional BrdU-based techniques in speed, accuracy, and compatibility with fluorescence microscopy.

• Applied Workflows for Cy5.5 NHS Ester in In Vivo Imaging

  2026-07-05

  Harnessing Cy5.5 NHS ester (non-sulfonated) enables researchers to achieve highly sensitive, stable, and reproducible near-infrared labeling of proteins and oligonucleotides for advanced in vivo fluorescence imaging. This article translates cutting-edge reference research into actionable protocols, troubleshooting insights, and innovative assay choices for optical tumor and biomolecule detection.

• Propranolol: Applied Protocols for Emotional Memory Modulati

  2026-07-04

  Propranolol, a non-selective β-adrenergic receptor blocker, is revolutionizing applied research on emotional memory and cardiovascular regulation. This guide delivers stepwise workflows, troubleshooting tactics, and actionable insights for leveraging Propranolol in experimental paradigms that demand reliability and translational impact.

• RNAi Screens Reveal Vesicular Transport in SARS-CoV-2 Releas

  2026-07-03

  Kerr et al. conducted a comprehensive RNAi screen to identify host factors critical to SARS-CoV-2 replication, focusing on the often-overlooked steps of viral assembly and egress. Their findings implicate vesicle-mediated exocytic transport, particularly Rab11a-dependent pathways, as essential for viral release and demonstrate that CDK9 inhibition can disrupt this process, highlighting potential host-targeted antiviral strategies.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow

  2026-07-03

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific fluorescence detection of goat IgG primary antibodies in ICC/IF, IHC, flow cytometry, and ELISA. It is intended strictly as a secondary antibody within validated immunodetection workflows, not for direct detection of antigens or non-goat primary antibodies.

• Cabazitaxel (XRP6258): Technical Guidance for Resistant Mode

  2026-07-02

  Cabazitaxel addresses microtubule disruption in taxane-resistant and P-glycoprotein-expressing tumor models, providing a research solution where conventional taxanes fail. It should be used only in DMSO- or ethanol-based workflows and is not suitable for aqueous systems or long-term solution storage.

• Fluorescein TSA Kits: Transforming Translational Signal Dete

  2026-07-02

  Explore how tyramide signal amplification via the Fluorescein TSA Fluorescence System Kit enables ultrasensitive, spatially precise detection of low-abundance biomolecules in translational research. Integrating mechanistic insights from protein and gene expression studies, recent advances in pituitary tumor biology, and future-facing workflow strategies, this article delivers actionable guidance to scientists seeking to elevate immunohistochemistry, immunocytochemistry, and in situ hybridization for mechanistic and clinical impact.

• Fluorescein TSA Fluorescence System Kit: Precision Signal Am

  2026-07-01

  The Fluorescein TSA Fluorescence System Kit empowers researchers to visualize low-abundance biomolecules with ultrasensitive, spatially precise amplification in IHC, ICC, and ISH. Its tyramide-based chemistry delivers robust, localized fluorescence even in challenging tissue contexts, supporting breakthrough discoveries in disease signaling and therapeutic research.

• Cyclodextrin Complexation Modulates Mianserin HCl Cytotoxici

  2026-07-01

  This study systematically investigated the molecular interaction between Mianserin Hydrochloride (MIA), a 5-HT2 receptor antagonist, and heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD). Contrary to expectations based on prior β-cyclodextrin inclusion complex research, the DM-β-CD complexation increased MIA cytotoxicity in cell models, highlighting the nuanced impact of host–guest chemistry on antidepressant research compounds.

• Eicosapentaenoic Acid in Cardiovascular and Immunity Researc

  2026-06-30

  Eicosapentaenoic Acid (EPA) empowers cardiovascular and immunological research with high-purity, reproducible omega-3 interventions. This article details advanced experimental workflows, troubleshooting strategies, and translational insights for bench scientists using EPA as a lipid-lowering and anti-inflammatory agent.

• Axitinib (AG 013736) in Advanced Angiogenesis Inhibition Ass

  2026-06-30

  Axitinib (AG 013736) empowers researchers with nanomolar potency and exceptional VEGFR selectivity for precise modulation of angiogenesis and tumor growth in vitro and in vivo. This guide distills validated workflows, troubleshooting insights, and experimental innovations to maximize reproducibility and interpretive power in cancer biology research.

• 1-myristoylglycerophosphocholine in Smooth Muscle and Fibros

  2026-06-29

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) offers unparalleled specificity for dissecting lipid signaling in both smooth muscle contraction studies and fibrosis models. This article translates the latest mechanistic research into actionable protocols, troubleshooting strategies, and advanced applications for investigators working at the interface of membrane biology and disease.

• LC–MS/MS Analysis of GS-441524 Prodrug Conversion Pathways

  2026-06-29

  This study presents a novel GS-441524 prodrug (NGP-1) with structural modifications designed to enhance oral bioavailability and anti-SARS-CoV-2 activity. The work introduces a validated LC–MS/MS method for tracking the conversion of NGP-1 to its active metabolite in vitro and in vivo, providing actionable insights for drug development and pharmacokinetic research.

• ApexPrep DNA Plasmid Miniprep Kit: Assay Fidelity for AML Ge

  2026-06-28

  Explore how the ApexPrep DNA Plasmid Miniprep Kit elevates molecular biology grade plasmid DNA extraction, with a unique focus on its impact in AML genomics and practical assay design. This article offers advanced insights and protocol guidance beyond standard miniprep discussions.

15718 records 1/1048 page Next 12345 下5页 Last page